Natalia Curto‐García

Statistics

Publications

Citations

788

H-Index

Active since

2015

Affiliations

Guy's and St Thomas' NHS Foundation Trust(Current)

King's College London

Hôpital Saint-Louis

Wroclaw Medical University

Azienda Ospedaliero-Universitaria Careggi

Natalia Curto‐García is an author at Guy's and St Thomas' NHS Foundation Trust specializing in medicine, hematology, and myeloproliferative neoplasms.

ORCID

Publications per year

2015–2025

Publications

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Claire Harrison, Jyoti Nangalia, Rebecca H. Boucher et al. · Journal of Clinical Oncology · 2023 · 142 citations · Full text

Medicine, Hematology, Pharmacology +8

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca et al. · Journal of Clinical Oncology · 2023 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán et al. · Leukemia · 2021 · 82 citations · Full text

Medicine, Hematology, Pharmacology +15

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

Emanuela Sant’Antonio, Paola Guglielmelli, Lisa Pieri et al. · American Journal of Hematology · 2019 · 72 citations · Full text

Medicine, Hematology, Pathology +17

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia

Patrick Harrington, Katie J. Doores, Deepti Radia et al. · British Journal of Haematology · 2021 · 64 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 22